Centessa Pharmaceuticals PLC (CNTA)
8.865
-0.08
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
8.865
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Total Liabilities (Quarterly): 113.01M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 113.01M |
| December 31, 2023 | 124.00M |
| September 30, 2023 | 117.97M |
| June 30, 2023 | 116.32M |
| March 31, 2023 | 110.60M |
| December 31, 2022 | 108.14M |
| September 30, 2022 | 106.43M |
| Date | Value |
|---|---|
| June 30, 2022 | 101.01M |
| March 31, 2022 | 102.04M |
| December 31, 2021 | 138.08M |
| September 30, 2021 | 63.07M |
| June 30, 2021 | 58.12M |
| March 31, 2021 | 41.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
41.89M
Minimum
Mar 2021
138.08M
Maximum
Dec 2021
100.05M
Average
108.14M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 328.17M |
| Shareholders Equity (Quarterly) | 215.16M |